中文
|
English
Home
|
Help
|
Contact
Return
Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
10.5045/br.2022.2021183
Author:
Jin-Hyo KIM
1
; Sung-Soo PARK ; Jae-Ho YOON ; Sung-Eun LEE ; Hee-Je KIM ; Chang-Ki MIN
Author Information
1. Department of Hematology, Seoul St. Mary’s Hematology Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Publication Type:
Letters to the Editor
From:
Blood Research 2022;57(1):76-80
Country
Republic of Korea
Language:
English